Wilfried Dinh

1.8k total citations · 1 hit paper
49 papers, 1.2k citations indexed

About

Wilfried Dinh is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wilfried Dinh has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wilfried Dinh's work include Cardiovascular Function and Risk Factors (16 papers), Heart Failure Treatment and Management (15 papers) and Cardiac Imaging and Diagnostics (9 papers). Wilfried Dinh is often cited by papers focused on Cardiovascular Function and Risk Factors (16 papers), Heart Failure Treatment and Management (15 papers) and Cardiac Imaging and Diagnostics (9 papers). Wilfried Dinh collaborates with scholars based in Germany, United States and Netherlands. Wilfried Dinh's co-authors include Mark Lankisch, Reiner Füth, Thomas Scheffold, Werner Nickl, Michael Coll Barroso, Adriaan A. Voors, Thomas Krahn, Frank Kramer, Faı̈ez Zannad and Steven R. Goldsmith and has published in prestigious journals such as Circulation, American Heart Journal and Nature Reviews Cardiology.

In The Last Decade

Wilfried Dinh

45 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment

2020 216 citations Wilfried Dinh, Finn Gustafsson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wilfried Dinh Germany	20	800	219	209	146	139	49	1.2k
Raghava S. Velagaleti United States	12	835 1.0×	174 0.8×	237 1.1×	143 1.0×	65 0.5×	21	1.1k
Nikolaos Fragakis Greece	22	1.2k 1.5×	238 1.1×	240 1.1×	247 1.7×	101 0.7×	168	1.7k
Kunio Yufu Japan	22	1.1k 1.4×	274 1.3×	248 1.2×	137 0.9×	100 0.7×	99	1.5k
Tanya L. Medley Australia	13	796 1.0×	142 0.6×	217 1.0×	150 1.0×	229 1.6×	15	1.4k
Luigi Gabrielli Chile	21	837 1.0×	405 1.8×	158 0.8×	95 0.7×	158 1.1×	87	1.5k
Valentina Milani Italy	18	473 0.6×	205 0.9×	249 1.2×	149 1.0×	186 1.3×	57	1.1k
Altin Palloshi Italy	15	671 0.8×	165 0.8×	182 0.9×	89 0.6×	94 0.7×	37	1.1k
Moriaki Inoko Japan	16	710 0.9×	233 1.1×	217 1.0×	51 0.3×	132 0.9×	98	1.1k
Xueyan Zhao China	17	474 0.6×	119 0.5×	313 1.5×	117 0.8×	104 0.7×	128	982
Beatrice Musumeci Italy	23	1.3k 1.6×	415 1.9×	184 0.9×	108 0.7×	115 0.8×	129	1.8k

Countries citing papers authored by Wilfried Dinh

Since Specialization

Citations

This map shows the geographic impact of Wilfried Dinh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Dinh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Dinh more than expected).

Fields of papers citing papers by Wilfried Dinh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfried Dinh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Dinh. The network helps show where Wilfried Dinh may publish in the future.

Co-authorship network of co-authors of Wilfried Dinh

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfried Dinh. A scholar is included among the top collaborators of Wilfried Dinh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfried Dinh. Wilfried Dinh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prochaska, Jürgen H., Thomas Muenzel, Wilfried Dinh, et al.. (2025). Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study. European Heart Journal - Digital Health. 6(2). 298–309.

Schulz, Andreas, Felix Müller, Wilfried Dinh, et al.. (2025). Role of Heart Rate Recovery in Chronic Heart Failure: Results From the MyoVasc Study. Journal of the American Heart Association. 14(10). e039792–e039792.

Udelson, James E., Steven R. Goldsmith, Daniel Burkhoff, et al.. (2025). A Multicentre, Randomized, Double-Blind, Active and Placebo-Controlled Study of Pecavaptan, a Dual V1a/V2 Vasopressin Receptor Antagonist, in Patients with Acute Heart Failure: The AVANTI Trial. European Journal of Heart Failure. 27(11). 2525–2536.

Peters, Anthony E., Karen Chiswell, Paul Hofmann, et al.. (2022). Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators. Current Problems in Cardiology. 48(3). 101520–101520. 3 indexed citations

Mondritzki, Thomas, Julia Vogel, Elisabeth Pook, et al.. (2020). Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. European Journal of Heart Failure. 23(5). 743–750. 18 indexed citations

Goldsmith, Steven R., Daniel Burkhoff, Finn Gustafsson, et al.. (2020). Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial. Journal of Cardiac Failure. 27(2). 233–241. 19 indexed citations

Hoppe, Matthias, Philip Boehme, Thomas Krahn, et al.. (2019). Test-Retest Reliability of Non-Invasive Cardiac Output Measurement during Exercise in Healthy Volunteers in Daily Clinical Routine. Arquivos Brasileiros de Cardiologia. 113(2). 231–239. 4 indexed citations

Bufe, Alexander, et al.. (2019). Impact of body mass index on acute outcome in percutaneous coronary intervention of chronic total occlusion. Journal of the Saudi Heart Association. 31(4). 198–203. 2 indexed citations

Farinacci, Maura, Thomas Krahn, Wilfried Dinh, et al.. (2018). Circulating endothelial cells as biomarker for cardiovascular diseases. Research and Practice in Thrombosis and Haemostasis. 3(1). 49–58. 51 indexed citations

10.

Mondritzki, Thomas, Philip Boehme, Julia Vogel, et al.. (2017). New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions. European Journal of Applied Physiology. 118(1). 195–203. 5 indexed citations

11.

Kramer, Frank, Hani N. Sabbah, Faı̈ez Zannad, et al.. (2017). Redefining the role of biomarkers in heart failure trials: expert consensus document. Heart Failure Reviews. 22(3). 263–277. 16 indexed citations

12.

Greene, Stephen J., Ami N. Shah, Javed Butler, et al.. (2014). Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries. American Heart Journal. 168(2). 142–149. 23 indexed citations

13.

Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2011). Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 28 indexed citations

14.

Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2011). Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?. Arquivos Brasileiros de Cardiologia. 97(1). 65–75. 23 indexed citations

15.

Haltern, Georg, et al.. (2011). Recanalisation of coronary chronic total occlusions with new techniques including the retrograde approach via collaterals. Netherlands Heart Journal. 19(4). 162–167. 27 indexed citations

16.

Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2010). Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. Diabetic Medicine. 28(3). 311–318. 37 indexed citations

17.

Dinh, Wilfried, Mark Lankisch, Werner Nickl, et al.. (2010). Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovascular Diabetology. 9(1). 63–63. 70 indexed citations

18.

Dinh, Wilfried, Werner Nickl, Frank Kramer, et al.. (2010). Reduced global longitudinal strain in association to increased left ventricular mass in patients with aortic valve stenosis and normal ejection fraction: a hybrid study combining echocardiography and magnetic resonance imaging. Cardiovascular Ultrasound. 8(1). 29–29. 39 indexed citations

19.

Sause, Armin, et al.. (2010). Limiting esophageal temperature in radiofrequency ablation of left atrial tachyarrhythmias results in low incidence of thermal esophageal lesions. BMC Cardiovascular Disorders. 10(1). 52–52. 41 indexed citations

20.

Füth, Reiner, et al.. (2009). Newly detected glucose disturbance is associated with a high prevalence of diastolic dysfunction: double risk for the development of heart failure?. Acta Diabetologica. 46(4). 335–338. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact